Introduction
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 21 March 2018. On the basis of the Risk Assessment Report — and on the initiative of the European Commission — on 27 September 2018, the Council decided that cyclopropylfentanyl should be subject to control measures across the Member States.
Download as PDF
Table of contents
- Foreword
- EMCDDA actions on monitoring and responding to new drugs
- EMCDDA‒Europol Joint Report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl): a summary
- Risk Assessment Report of a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl)
- Annex 1: Technical report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl)
- Participants of the risk assessment meeting
Pages:
58
Price:
Free
ISBN:
978-92-9497-351-1
ISSN:
1725-4493
Pub. DOI:
10.2810/895612
Related links